Table 2.

The relationship between FOXK2 and clinicopathologic characteristics in the validated cohort.

	Case(n)	FOXK2 folda	P-value
Gender
Male	27	6.0(3.0-8.5)	0.153
Female	71	4.0(2.0-7.0)
Age
<55	75	5.5(2.0-8.5)	0.401
≥55	23	5.0(2.5-8.0)
Tumor Size
< 2 cm	50	3.5(2.0-5.0)	0.001*
≥2 cm	48	6.8(2.5-10.0)
LNM
Yes	62	5.0(2.0-7.5)	0.504
No	36	5.0(2.5-8.0)
TNM Stage
I+II	62	4.0(2.0-6.0)	0.013*
III+IV	36	7.0(3.0-9.5)

*Indicated statistical significance (P<0.05).

^aMedian of relative expression according to HSCORE system, with 25th-75th percentile in parenthesis.

LNM, lymph node metastasis.